Shares of ResMed (NYSE:RMD) fell 6% today, despite the company reporting second-quarter earnings that surpassed analyst ...

In a report released today, Brett Fishbin from KeyBanc maintained a Buy rating on Resmed (RMD – Research Report), with a price target of ...

ResMed Inc . (NYSE:RMD) stock has achieved a remarkable milestone, soaring to a 52-week high of $260.71. With a market capitalization of $38.2 billion, the medical equipment giant maintains a strong ...

Needham analyst Michael Matson has maintained their neutral stance on RMD stock, giving a Hold rating on January 29.Invest with Confidence: ...

ResMed is taking a “smart devices” and ... The duopolistic nature of the market is also in the best interest of durable medical equipment, or DME, suppliers as it limits the number of device ...

Sleep device giant ResMed expects to benefit from Donald Trump’s trade tariffs and tax cuts if competitors making rival products in China and Mexico are slapped with additional duties when they ...

Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

Aaron Wealth Advisors LLC lifted its holdings in shares of ResMed Inc. (NYSE:RMD – Free Report) by 25.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional ...

Shares of ResMed Inc. RMD rose 1.67% to $254.70 Monday, on what proved to be an all-around mixed trading session for the ...

ResMed has beaten earnings forecasts in the second quarter due to higher sales of its sleep device products and masks despite fears that the take-up of weight-loss drugs would reduce demand as ...

Ritholtz Wealth Management lessened its holdings in shares of ResMed Inc. (NYSE:RMD – Free Report) by 79.7% in the fourth ...

Learn more about whether Penumbra, Inc. or ResMed Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.